What institutional consolidation actually looks like

By Andy Sloan

17 May 2026 · 2 min read

That's not wrong. It's where most markets start. It's where the UK dental sector is now.

But in North America, the most sophisticated institutional capital has moved to a different conversation entirely. And it's worth understanding what that conversation looks like, because it tells you something important about where this market is heading.

I've been involved in more than 120 acquisitions across the UK dental sector. I've watched how capital thinks about dental as it matures. And the North American model is the most instructive example of what comes after the growth phase.

A major institutional investor has built positions across nearly every layer of the North American dental market. They own the largest DSO in the US. They're invested in the largest DSO in Canada. They hold a significant stake in the world's largest dental distributor, which owns the PMS platform used by more than 48,000 practices and 90% of the top 50 DSOs. They control claims processing infrastructure.

No single layer of this is remarkable on its own. What's remarkable is the architecture.

Think about what each layer does. The DSO gives you clinical scale and patient volume. The distributor gives you supply chain efficiency and margin. The PMS gives you daily operational data across tens of thousands of practices, not just your own, but across the market. The claims infrastructure gives you visibility into cash conversion across the entire system.

When these layers work together, something changes. You're not just running a dental business. You're running the infrastructure that the dental market depends on. Your data advantage compounds. Your operational efficiency compounds. Your ability to understand what practices need, before they know themselves, compounds.

This is what sophisticated institutional capital looks for. Not just growth. Architecture. Not just revenue. Infrastructure that becomes more valuable as the market scales around it.

The UK market will get here. Not immediately. But the trajectory of consolidation in every mature healthcare market points in the same direction. Capital starts with growth, then moves to operational efficiency, then moves to infrastructure control. We are at the operational efficiency stage. The infrastructure stage is the one to watch.

For UK dental group leaders, the question this raises is straightforward. When capital in this market reaches that level of sophistication, and it will, what will it be looking for? Not just how many practices you've acquired or what your EBITDA looks like. It will be looking at whether you've built something with genuine infrastructure value. Whether your data, your systems, your operational model gives an acquirer something they can build on, not just something they can add to.

That's a different question from the one most groups are asking right now. It's worth asking it earlier than you think you need to.

Next read: The three prices of a dental business →